All-Atom MD Simulations of the HBV Capsid Complexed with AT130 Reveal Secondary and Tertiary Structural Changes and Mechanisms of Allostery
The hepatitis B virus (HBV) capsid is an attractive drug target, relevant to combating viral hepatitis as a major public health concern. Among small molecules known to interfere with capsid assembly, the phenylpropenamides, including AT130, represent an important antiviral paradigm based on disrupti...
Main Authors: | Carolina Pérez-Segura, Boon Chong Goh, Jodi A. Hadden-Perilla |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/4/564 |
Similar Items
-
All-Atom MD Simulations of the HBV Capsid Complexed with AT130 Reveal Secondary and Tertiary Structural Changes and Mechanisms of Allostery
by: Pérez-Segura, Carolina, et al.
Published: (2021) -
All-atom molecular dynamics of the HBV capsid reveals insights into biological function and cryo-EM resolution limits
by: Jodi A Hadden, et al.
Published: (2018-04-01) -
Novel Antivirals in Clinical Development for Chronic Hepatitis B Infection
by: Lung-Yi Mak, et al.
Published: (2021-06-01) -
Surface Charge Density Effect On HBV Capsid Assembly Behavior In Solution
by: Sun, Xinyu
Published: (2016) -
Evans Blue Inhibits HBV Replication Through a Dual Antiviral Mechanism by Targeting Virus Binding and Capsid Assembly
by: Yu Xiao, et al.
Published: (2019-11-01)